Joi + Blokes review

The FDA letter is specific to this business

The FDA issued warning letter 728283, to Joi and Blokes doing business as Joi + Blokes over false or misleading claims concerning compounded semaglutide and tirzepatide. That disclosure belongs beside the offer rather than being lost beneath a lower introductory price. Read the cited claims and ask how the company now explains the actual preparation it proposes. A regulatory letter is a dated finding, not a personal assessment of an individual patient's outcome or proof that every later order is identical.

Joi + Blokes presents a women's hormone and wellness brand alongside its Blokes men's offering. That broader focus can be relevant to someone wanting several concerns discussed, but it does not establish that every weight concern has a hormonal cause or that additional hormone treatment is appropriate. The company's own description says medical care comes from independent clinician groups. Ask which practice and professional will assess you and how their scope fits your particular history before treating a broad wellness menu as an integrated clinical plan.

The advertised monthly amounts are billed quarterly

Compounded semaglutide is advertised at $179 per month after a $99 first month, and tirzepatide at $249 after a $149 first month. The program is billed quarterly, and the terms require at least three consecutive months of service. Those are not ordinary no-commitment monthly purchases. Request the actual initial quarterly charge, the ongoing quarterly total, the supply schedule, and the renewal authorization rather than assuming the introductory amount is all that will be collected at enrollment.

The program lists medication, dosing support, clinician consultations, and health coaching as included, with unlimited health-coach visits. Ask which contact reaches the prescriber and which reaches a coach. The company explicitly says coaches are not doctors; their support should not replace clinical decisions about a prescription. Labs are described as optional rather than required. Confirm their separate cost and the clinician's actual assessment plan rather than assuming every panel or other service is included in the weight-management price.

Branded Zepbound is care plus a separate pharmacy bill

The Zepbound program costs $297 for a three-month service, advertised as $99 per month, excluding medication. Vials are purchased separately through LillyDirect under the manufacturer's applicable terms. The $99 amount is therefore not a complete Zepbound treatment price. Obtain the exact medication, dose, pharmacy charge, and care total before comparing this route with the compounded package. Insurance or manufacturer eligibility should be checked for the actual prescription rather than inferred from the presence of a branded option.

The terms name several pharmacy partners, including Strive, The Pharmacy Hub, Tailor Made Compounding, Cadre Labs, Empower, LillyDirect/GiftHealth, and Partell. Confirm the actual licensed dispenser for your order. A partner list is useful accountability information without establishing identical products across pharmacies. Compounded medications are not FDA approved. Obtain full ingredients, concentration, quantity, storage, and instructions, particularly if switching from a previous preparation or discussing another route alongside a brand.

Cancellation language has a minimum-term limit

The product page says plans can be adjusted or canceled anytime, while the terms require a three-month minimum and notice 30 days before the next processing date. Products are described as nonrefundable, with a separate promise of a refund if a clinician decides prescribing is inappropriate. Clarify how those rules interact before paying. Stopping future service does not automatically undo a quarter already purchased, and an approval-related refund should not be expanded into a general satisfaction guarantee.

Joi + Blokes may interest someone seeking coaching and a broader wellness context, provided the actual clinical relationship and payment term are clear. Its GLP-1 page does not publish a complete state list or substantive postpartum and breastfeeding guidance. Confirm location, relevant reproductive circumstances, and coordination with existing care directly. The useful comparison keeps the FDA letter, quarterly minimum, introductory month, and separate branded medication bill visible together rather than treating a monthly-looking figure as the whole commitment.